C-REACTIVE PROTEIN EVALUATION OF MEDICALLY TREATED CASES OF PYOMETRA IN DOGS

Abstract

The potential of biomarkers as diagnostic or prognostic tool in canine pyometra is under investigation. The CRP evaluation of pyometra-affected dogs revealed very high levels (128.51 ± 4.07 to 136.64 ± 6.77 μg/mL) on the day of admission. The levels returned to normal after medical treatment (10.00 ± 0.28 to 12.01 ± 2.49 μg/mL) in all the treatment groups by day 15 after initiation of treatment, which was in parallel to clinical recovery. The present study revealed that CRP can be considered as effective end point marker to evaluate efficacy of the treatment

Keywords

• crp
• medical management
• pyometra
• dog.